{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T05:25:31Z","timestamp":1743398731312},"reference-count":14,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T00:00:00Z","timestamp":1373932800000},"content-version":"vor","delay-in-days":1657,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Procedia in Vaccinology"],"published-print":{"date-parts":[[2009]]},"DOI":"10.1016\/j.provac.2009.07.019","type":"journal-article","created":{"date-parts":[[2009,8,27]],"date-time":"2009-08-27T10:46:37Z","timestamp":1251369997000},"page":"104-109","source":"Crossref","is-referenced-by-count":16,"title":["Nucleoside hydrolase DNA vaccine against canine visceral leishmaniasis"],"prefix":"10.1016","volume":"1","author":[{"given":"GP","family":"Borja-Cabrera","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"FB","family":"Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E","family":"Picillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"AE","family":"Gravino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"Manna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"CB","family":"Palatnik-de-Sousa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.provac.2009.07.019_bib1","first-page":"1068","article-title":"A Phase III trial of Efficacy of the FML- vaccine against canine kala-azar in an endemic area of Brazil(S\u00e3o Gon\u00e7alo do Amarante, RN)","volume":"19","author":"da Silva","year":"2001","journal-title":"Vaccine."},{"key":"10.1016\/j.provac.2009.07.019_bib2","doi-asserted-by":"crossref","first-page":"4991","DOI":"10.1016\/j.vaccine.2008.07.029","article-title":"Immunogenicity assay of the Leishmune \u00ae vaccine against canine visceral leishmaniasis in Brazil","volume":"26","author":"Borja-Cabrera","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.provac.2009.07.019_bib3","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1016\/j.vaccine.2003.11.039","article-title":"Effective Immunotherapy against canine visceral leishmaniasis with the FML-vaccine","volume":"22","author":"Borja-Cabrera","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.provac.2009.07.019_bib4","doi-asserted-by":"crossref","first-page":"6176","DOI":"10.1016\/j.vaccine.2007.06.005","article-title":"Immunotherapy against experimental canine visceral leishmaniasis with the saponin enriched-Leishmune\u00ae vaccine","volume":"25","author":"Santos","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.provac.2009.07.019_bib5","doi-asserted-by":"crossref","unstructured":"Palatnik-de-Sousa CB, Silva-Antunes I, Morgado AA, Menz I, Palatnik M, Lavor C. Decrease of the incidence of human and canine visceral leishmaniasis after dog vaccination with Leishmune\u00ae in Brazilian endemic areas. Vaccine 2009;.(in press).","DOI":"10.1016\/j.vaccine.2009.03.045"},{"key":"10.1016\/j.provac.2009.07.019_bib6","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0166-6851(02)00010-5","article-title":"Nucleoside Hydrolase from Leishmania (L.) donovani is an Antigen Diagnostic for Visceral Leishmaniasis","volume":"120","author":"Santana","year":"2002","journal-title":"Mol Biochem Parasitol"},{"key":"10.1016\/j.provac.2009.07.019_bib7","doi-asserted-by":"crossref","first-page":"9375","DOI":"10.1073\/pnas.0703678104","article-title":"Evolutionary and geographical history of the Leishmania donovani complex with a revision of current taxonomy","volume":"104","author":"Lukes","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.provac.2009.07.019_bib8","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1128\/IAI.73.2.812-819.2005","article-title":"Cross-protective efficacy of a prophylactic Leishmania donovani DNA vaccine against visceral and cutaneous murine leishmaniasis","volume":"73","author":"Aguilar-Be","year":"2005","journal-title":"Inf Immun"},{"key":"10.1016\/j.provac.2009.07.019_bib9","doi-asserted-by":"crossref","first-page":"296","DOI":"10.4269\/ajtmh.1999.61.296","article-title":"The FML-ELISA assay in diagnosis and prognosis of canine visceral leishmaniasis","volume":"6","author":"Borja Cabrera","year":"1999","journal-title":"Am J Trop Med"},{"key":"10.1016\/j.provac.2009.07.019_bib10","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1051\/vetres:2008013","article-title":"Slc11a1 (formerly Nramp1) and susceptibility to canine visceral leishmaniasis","volume":"39","author":"Sanchez-Robert","year":"2008","journal-title":"Vet Res"},{"key":"10.1016\/j.provac.2009.07.019_bib11","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.vetpar.2006.06.028","article-title":"Leishmania DNA load and cytokine expression levels in asymptomatic naturally infected dogs","volume":"142","author":"Manna","year":"2006","journal-title":"Vet Parasitol"},{"key":"10.1016\/j.provac.2009.07.019_bib12","doi-asserted-by":"crossref","first-page":"287","DOI":"10.4269\/ajtmh.1995.52.287","article-title":"Control of zoonotic visceral leishmaniasis. Is it time to change strategies?","volume":"52","author":"Tesh","year":"1995","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.provac.2009.07.019_bib13","doi-asserted-by":"crossref","first-page":"3716","DOI":"10.1016\/j.vaccine.2005.02.009","article-title":"Protective vaccination against canine visceral leishmaniasis using a combination of DNA and protein immunization with cysteine proteinases TypeI and Type II of L. infantum","volume":"23","author":"Rafati","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.provac.2009.07.019_bib14","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1016\/S0264-410X(03)00032-X","article-title":"Protection in dogs against visceral leishmaniasis caused by Leishmania infantum is achieved by immunization with a heterologous prime-boost regime using DNA vaccine and vaccinia recombinant vectors expressing LACK","volume":"21","author":"Ramiro","year":"2003","journal-title":"Vaccine"}],"container-title":["Procedia in Vaccinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877282X09000502?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877282X09000502?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T06:40:18Z","timestamp":1558507218000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1877282X09000502"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009]]}},"alternative-id":["S1877282X09000502"],"URL":"https:\/\/doi.org\/10.1016\/j.provac.2009.07.019","relation":{},"ISSN":["1877-282X"],"issn-type":[{"value":"1877-282X","type":"print"}],"subject":[],"published":{"date-parts":[[2009]]}}}